Talk Title: Genome editing of T cells for cancer immunotherapy

Chiara Bonini, M.D., Professor of Hematology at the University Vita-Salute San Raffaele, Director of the Program of Cancer Immune-Gene Therapy and Head of the Experimental Hematology Lab at IRCCS San Raffaele Scientific Institute. She was trained in Milano (Ospedale San Raffaele – OSR), New York (MSKCC) and Seattle (FHCRC). Prof. Bonini has received several prestigious awards, including the Young Investigator Award from the American Society of Gene and Cell Therapy (ASGCT, 2005), the Van Bekkum Award from the European Society of Bone Marrow Transplantation (EBMT, 2012, 2016), the Outstanding Achievement Award from the European Society of Gene and Cell Therapy (ESGCT 2024), the Outstanding Achievement Award, NVGCT 2024),the DKMS Mechtild Harf Science Award 2025, Ham Wasserman Lecture at ASH 2025.
She has served on the executive committees of various scientific societies of cell and gene therapy, hematology and stem cell transplantation including ASGCT, ESGCT, EHA and EBMT.

Her main research focus is allogeneic stem cell transplantation and the development, preclinical and clinical validation of cell and gene therapy approaches to treat cancer. Her scientific production includes > 200 papers in international scientific journals, >10 international patents. She has been Invited speaker at > 230 International Meetings, Workshops and Universities.